OrbiMed Israel GP II, L.P.
SEC CIK 1682090 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ACET | Adicet Bio, Inc. | Dir, 10% | 242.3K | — | — | 1 | 2021-12-10 | 2021-12-10 |
Most active insiders at ACET, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ORBIMED ADVISORS LLC | 10% | $5.00M | $674.8K |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 10% | $1.60M | — |
| 3 | Aftab Blake | CSO | — | — |
| 4 | Healey Don | CTO | — | — |
| 5 | Harvey Brian Nicholas | CFO | — | — |
| 6 | Schor Chen | Pres, CEO, Dir | — | — |
OrbiMed Israel GP II, L.P. made no open-market trades at ACET in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2021-12-14 | 2021-12-10 | ACET | Adicet Bio, Inc. | OrbiMed Israel GP II, L.P. | Dir, 10% | A - Grant | $14.00 | +214.3K | 242.3K | +765% | +$3.00M |
Purchase Sale Sale after option exercise All abbreviations